Diabetic patient starts producing insulin on his own after implantation of genetically modified cells
A man from type 1 diabetes mellitus became the world’s first patient to start producing his own insulin after transplantation of genetically modified cells.
They wanted mammoths, but got mice: Colossal BioSciences startup has bred woolly rodents
Geneticists and bioengineers at Colossal BioSciences have bred woolly mice as part of a project to revive mammoths.
CRISPR gene editing tool helps partially restore vision to blind patients in clinical trials
We are talking about patients with Leber’s amaurosis, a rare congenital retinal disease that affects about one in 40 thousand newborns. The genetic mutation leads to complete blindness in about a third of patients, and there are currently no approved treatment options.
Spelling error report
The following text will be sent to our editors: